Demir Aşırı Birikimi Hastalıkları

Cathcart J, mukhopadhya A. European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis. Frontline Gas troenterol. 2023;14(4):282-6.

ACG Clinical Guideline: Hereditary Hemochromatosis. The American Journal of Gastroenterology 114(8): p 1202-1218, August 2019.

Anderson GJ, Frazer DM, McLaren GD. Iron absorption and metabolism. Curr Opin Gastroenterol. 2009;25(2):129–35.

Liu Yin J, Cussen C, Harrington C, Foskett P, raja K, Ala A. Guideline review: European Association for the Study of Liver (EASL) Clinical Practice Guidelines on Haemochromatosis. J Clin Exp Hepatol. 2023;13(4):649-655.

Bacon BR, Adams PC, Kowdley KV, et al; American Association for the Study of Liver D. Diagnosis and management of hemochromatosis:2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54.328-43.

Hebbel RP. Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol 1985; 14.129.

Brissot P, Pietrangelo A, Adams PC, et al. Nature reviews. Dis Primers 2018; 4.18016.

Bacon BR, Kwiatkowski JL. Approach to the patient with suspected iron overload. Uptodate. Literature review current through: May 2022. | This topic last updated: Jun 09, 2022.

Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. Am J Gastroenterol 2019; 114:1202-18.

Pilling LC, et al. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ. 2019 Jan 16;364: k5222.

McDonnel SM, Preston BL, Jewell SA, et al. A survey of 2851 patients with hemochromatosis: Symptoms and response to treatment. Am J Med 1999; 106:619-24.

Powell LW, Dixon JL, Ramm GA, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006; 166:294-301.

Pietrangelo A. Iron and the liver. Liver Int 2016; 36 Suppl 1.116.

Beutler E. Hemochromatosis: genetics and pathophysiology. Annu Rev Med 2006; 57.331-47.

Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139(2):393-408, 408.e1-2.

Pelusi C, Gasparini DI, Bianchi N, et al. Endocrine dysfunction in hereditary hemochromatosis. J Endocrinol Invest 2016; 39.837-47.

Carroll GJ, Breidahl WH, Bulsara MK, et al. Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 2011; 63:28694.

Olynyk JK, Ramm GA (8 December 2022). "Hemochromatosis". New England Journal of Medicine. 387 (23): 2159–70.

Beaton M, Guyader D, Deugnier Y, et al. Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36.673-8.

Bacon BR, Adams PC, Kowdley KV, et al; American Association for the Study of Liver D. Diagnosis and management of hemochromatosis:2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54.328-43.

Wood JC. Guidelines for quantifying iron overload. Hematology Am Soc Hematol Educ Program 2014; 2014:210.

Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012;10(4):411–22.

Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343:327.

Cullis JO, Fitzsimons EJ, Griffiths WJ, et al. Investigation and management of a raised serum ferritin. Br J Haematol 2018; 181:331.

European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010; 53,3-22.

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022 Aug;77(2):479-502.